13F filer · CIK 2106939
PSP Research LLC
LAS VEGAS, NV · filing since Q4 2025 · last filing Oct 21, 2026
Reported value
$145.8M
$-42.1M vs prior
Positions
44
New / sold out
1 / 32
Added / reduced
0 / 27
Turnover
3.0%
buys $5.0M · sells $46.0M
Top-10 weight
95.0%
Biggest buys vs Q2 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | SERA PROGNOSTICS INC | +2,396,685 | – | +$5.0M |
Biggest sells vs Q2 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | SPDR SERIES TRUST | -183,500 | -32.2% | $-28.9M |
| Sold out | DISC MEDICINE INC | -8,000 | -100.0% | $-585.1K |
| Sold out | RAPPORT THERAPEUTICS INC | -14,000 | -100.0% | $-583.4K |
| Sold out | ULTRAGENYX PHARMACEUTICAL IN | -17,000 | -100.0% | $-567.6K |
| Sold out | MONTE ROSA THERAPEUTICS INC | -23,000 | -100.0% | $-556.6K |
| Sold out | IONIS PHARMACEUTICALS INC | -6,800 | -100.0% | $-539.2K |
| Sold out | PHARVARIS N V | -15,000 | -100.0% | $-518.7K |
| Sold out | ACADIA PHARMACEUTICALS INC | -19,766 | -100.0% | $-500.1K |
| Sold out | PTC THERAPEUTICS INC | -6,000 | -100.0% | $-489.4K |
| Sold out | CELLDEX THERAPEUTICS INC NEW | -13,000 | -100.0% | $-483.7K |
49 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ISHARES TR0-3 MTH TREASURY | 700,000 | $70.5M | 48.33% |
| 2 | SPDR SERIES TRUSTST STR SP BIOT | 386,500 | $60.9M | 41.79% |
| 3 | SERA PROGNOSTICS INCCLASS A COM | 2,396,685 | $5.0M | 3.43% |
| 4 | HALOZYME THERAPEUTICS INCCOM | 3,000 | $331.2K | 0.23% |
| 5 | MADRIGAL PHARMACEUTICALS INCCOM | 600 | $302.4K | 0.21% |
| 6 | EXELIXIS INCCOM | 5,000 | $292.1K | 0.20% |
| 7 | ROYALTY PHARMA PLCSHS CLASS A | 5,000 | $291.8K | 0.20% |
| 8 | ARGENX SESPONSORED ADR | 300 | $287.7K | 0.20% |
| 9 | NURIX THERAPEUTICS INCCOM | 12,000 | $284.5K | 0.20% |
| 10 | TG THERAPEUTICS INCCOM | 5,000 | $278.9K | 0.19% |
34 more rows. Subscribe for $29/month to see every row, download the data and use the API.